DK318189D0 - Fremgangsmaade til reendothelisering af blodkar - Google Patents

Fremgangsmaade til reendothelisering af blodkar

Info

Publication number
DK318189D0
DK318189D0 DK318189A DK318189A DK318189D0 DK 318189 D0 DK318189 D0 DK 318189D0 DK 318189 A DK318189 A DK 318189A DK 318189 A DK318189 A DK 318189A DK 318189 D0 DK318189 D0 DK 318189D0
Authority
DK
Denmark
Prior art keywords
reendothelization
bloods
procedure
Prior art date
Application number
DK318189A
Other languages
English (en)
Other versions
DK318189A (da
Inventor
Anthony R Carabasi
Bruce E Jarrel
Stuart K Williams
Original Assignee
Univ Jefferson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jefferson filed Critical Univ Jefferson
Publication of DK318189D0 publication Critical patent/DK318189D0/da
Publication of DK318189A publication Critical patent/DK318189A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06—Blood vessels
    • A61F2/062—Apparatus for the production of blood vessels made from natural tissue or with layers of living cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK318189A 1987-10-28 1989-06-27 Fremgangsmaade til reendothelisering af blodkar DK318189A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/114,242 US4883755A (en) 1987-10-28 1987-10-28 Method of reendothelializing vascular linings
PCT/US1988/003740 WO1989003875A1 (en) 1987-10-28 1988-10-24 Method of reendothelializing vascular linings

Publications (2)

Publication Number Publication Date
DK318189D0 true DK318189D0 (da) 1989-06-27
DK318189A DK318189A (da) 1989-08-28

Family

ID=22354137

Family Applications (1)

Application Number Title Priority Date Filing Date
DK318189A DK318189A (da) 1987-10-28 1989-06-27 Fremgangsmaade til reendothelisering af blodkar

Country Status (11)

Country Link
US (1) US4883755A (da)
JP (1) JPH02502021A (da)
KR (1) KR970005044B1 (da)
AU (1) AU610292B2 (da)
CA (1) CA1325153C (da)
DE (1) DE3891033C2 (da)
DK (1) DK318189A (da)
FI (1) FI893126L (da)
NL (1) NL8820948A (da)
SE (1) SE501117C2 (da)
WO (1) WO1989003875A1 (da)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693625A (en) * 1989-03-09 1997-12-02 Therapeutiques Substitutives Method of regenerating cells and tissues using functionalized dextrans
US5705732A (en) * 1989-06-12 1998-01-06 Oklahoma Medical Research Foundation Universal donor cells
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
WO1991018639A1 (en) * 1990-05-30 1991-12-12 Alpha Therapeutic Corporation Method for using fibronectin in conjunction with percutaneous transluminal coronary angioplasty
US5500409A (en) * 1990-10-01 1996-03-19 Thomas Jefferson University Method for inhibiting collagen synthesis by keloid fibroblasts
EP1041142A3 (en) * 1991-07-15 2007-10-24 Oklahoma Medical Research Foundation Universal donor cells
US6916654B1 (en) * 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
US5957972A (en) * 1992-09-29 1999-09-28 Arizona Board Of Regents On Behalf Of The University Of Arizona Implants possessing a surface of endothelial cells genetically-modified to inhibit intimal thickening
US5716394A (en) * 1994-04-29 1998-02-10 W. L. Gore & Associates, Inc. Blood contact surfaces using extracellular matrix synthesized in vitro
EP0757562A1 (en) * 1994-04-29 1997-02-12 W.L. Gore & Associates, Inc. Improved blood contact surfaces using endothelium on a subendothelial extracellular matrix
AU2369695A (en) * 1994-04-29 1995-11-29 W.L. Gore & Associates, Inc. Improved blood contact surfaces employing natural subendothelial matrix and method for making and using the same
JP3687975B2 (ja) * 1994-07-01 2005-08-24 エドワーズ ライフサイエンシーズ コーポレイション 自己由来の微小血管内皮細胞を含む脂肪組織を採取する方法
US5804366A (en) * 1995-02-09 1998-09-08 Baxter International Inc. Method and apparatus for sodding microvessel cells onto a synthetic vascular graft
US5830879A (en) 1995-10-02 1998-11-03 St. Elizabeth's Medical Center Of Boston, Inc. Treatment of vascular injury using vascular endothelial growth factor
US6020196A (en) * 1996-05-09 2000-02-01 Baxter International Inc. Devices for harvesting and homogenizing adipose tissue containing autologous endothelial cells
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
US8075880B2 (en) 1999-01-11 2011-12-13 Steward St. Elizabeth's Medical Center Of Boston, Inc. Compositions and methods for regulating angiogenesis
US6471723B1 (en) * 2000-01-10 2002-10-29 St. Jude Medical, Inc. Biocompatible prosthetic tissue
DE10138564B4 (de) * 2001-08-06 2007-07-12 Lamm, Peter Wilhelm, Dr. Verfahren zur Devitalisierung natürlicher Organe und/oder zur Bereitstellung extrazellulärer Matrices zum "Tissue-Engineering"
US20030054331A1 (en) * 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
US7371258B2 (en) 2001-10-26 2008-05-13 St. Jude Medical, Inc. Valved prosthesis with porous substrate
US20030093147A1 (en) * 2001-11-13 2003-05-15 Ogle Matthew F. Medical devices that stimulate growth factor production
US7771716B2 (en) 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
US20060204556A1 (en) * 2001-12-07 2006-09-14 Cytori Therapeutics, Inc. Cell-loaded prostheses for regenerative intraluminal applications
US8404229B2 (en) 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
JP4653952B2 (ja) 2001-12-07 2011-03-16 サイトリ セラピューティクス インコーポレイテッド 処理済み脂肪吸引細胞で患者を治療するためのシステムと方法
US20050048035A1 (en) 2001-12-07 2005-03-03 Fraser John K. Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US20050095228A1 (en) 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US20050008626A1 (en) * 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
EP1467746A4 (en) * 2001-12-20 2006-10-04 Macropore Inc SYSTEMS AND METHODS FOR TREATING PATIENTS WITH COLLAGEN-RICH MATERIAL EXTRACTED FROM ADIPOSE TISSUES
US7470538B2 (en) 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
WO2005007034A1 (en) * 2003-07-08 2005-01-27 The Children's Hospital Of Philadelphia Steroid lipid-modified polyurethane as an implantable biomaterial, the preparation and uses thereof
DK1759536T3 (da) 2004-06-01 2011-09-05 Kwalata Trading Ltd In vitro-teknikker til anvendelse med stamceller
JP5138384B2 (ja) * 2005-01-10 2013-02-06 サイトリ セラピューティクス インコーポレイテッド 医療装置を監視し、管理し、サービスするための装置及び方法
US7789872B2 (en) * 2005-03-23 2010-09-07 Shippert Ronald D Tissue transplantation method and apparatus
US7794449B2 (en) * 2005-03-23 2010-09-14 Shippert Ronald D Tissue transplantation method and apparatus
US8062286B2 (en) * 2005-03-23 2011-11-22 Shippert Ronald D Tissue transplantation method and apparatus
US9581942B1 (en) 2005-03-23 2017-02-28 Shippert Enterprises, Llc Tissue transfer method and apparatus
US8622997B2 (en) * 2005-03-23 2014-01-07 Ronald D. Shippert Tissue transfer method and apparatus
EP1989290B1 (en) * 2006-03-07 2015-07-08 Humacyte Method for endothelial cell extraction from adipose tissues
TW200734462A (en) 2006-03-08 2007-09-16 In Motion Invest Ltd Regulating stem cells
US20090304644A1 (en) * 2006-05-30 2009-12-10 Cytori Therapeutics, Inc. Systems and methods for manipulation of regenerative cells separated and concentrated from adipose tissue
US20100015104A1 (en) * 2006-07-26 2010-01-21 Cytori Therapeutics, Inc Generation of adipose tissue and adipocytes
US7632340B2 (en) * 2007-03-07 2009-12-15 Hamilton Beach Brands, Inc. Air purifier for removing particles or contaminants from air
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
WO2010033820A1 (en) * 2008-09-19 2010-03-25 University Of Louisville Research Foundation, Inc. Bioreactors, systems, and methods for vascularizing tissue constructs
KR101738324B1 (ko) 2009-05-01 2017-05-19 비미니 테크놀로지스 엘엘씨 조직 및 세포 부유화 이식편의 최적화 시스템, 방법 및 조성물
EP2542249A4 (en) 2010-03-05 2013-08-07 Tissue Genesis Inc METHOD AND COMPOSITIONS FOR SUPPORTING TISSUE INTEGRATION AND INOCULATION OF TRANSPLANTED TISSUE AND TRANSPLANTED TREATED PENIS FABRIC WITH FAT FABRIC ACETIC COSTS
US8887770B1 (en) 2011-03-17 2014-11-18 Ronald D. Shippert Vessel fill control method and apparatus
US9468709B2 (en) 2012-11-12 2016-10-18 Shippert Enterprises, Llc Syringe fill method and apparatus
US10772997B2 (en) 2014-05-15 2020-09-15 Ronald D. Shippert Tissue parcelization method and apparatus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59214935A (ja) * 1983-05-20 1984-12-04 Hitachi Ltd デ−タ入力方法

Also Published As

Publication number Publication date
FI893126A0 (fi) 1989-06-27
AU610292B2 (en) 1991-05-16
FI893126A7 (fi) 1989-06-27
AU2610388A (en) 1989-05-23
KR890701727A (ko) 1989-12-21
DK318189A (da) 1989-08-28
KR970005044B1 (ko) 1997-04-11
SE8902344L (sv) 1989-08-25
US4883755A (en) 1989-11-28
FI893126L (fi) 1989-06-27
DE3891033C2 (de) 1998-04-16
SE501117C2 (sv) 1994-11-21
SE8902344D0 (sv) 1989-06-28
WO1989003875A1 (en) 1989-05-05
CA1325153C (en) 1993-12-14
NL8820948A (nl) 1989-09-01
JPH02502021A (ja) 1990-07-05

Similar Documents

Publication Publication Date Title
DK318189D0 (da) Fremgangsmaade til reendothelisering af blodkar
DK220586A (da) Fremgangsmaade til fremstilling af zeoliter
DK299284A (da) Fremgangsmaade til fraktionering af fedt
DK328788D0 (da) Fremgangsmaade til fremstilling af et aromatiseringsmiddel
DK214585D0 (da) Fremgangsmaade til fremstilling af imidazorifamyciner
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK573888D0 (da) Fremgangsmaade til fremstilling af paramunitetsinducere
DK314988A (da) Fremgangsmaade til fremstilling af 6-deoxyguaninderivater
DK162097C (da) Fremgangsmaade til fremstilling af riboflavin
DK323888A (da) Fremgangsmaade til hydrogenering af dobbeltbindinger
DK258886A (da) Fremgangsmaade til fremstilling af alkyloxiraner
DK79685A (da) Fremgangsmaade til fremstilling af riboflavin
DK509986D0 (da) Fremgangsmaade til fremstilling af aryl-cyanamider
DK505888A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK504988D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK163830C (da) Fremgangsmaade til fremstilling af riboflavin
DK130992D0 (da) Fremgangsmaade til fremstilling af angiotenxinomdannende enzyminhibitorer
DK564985D0 (da) Fremgangsmaade til fremstilling af alkylthioacetamidiner
DK115088A (da) Indretning til sammensoemning af konstruktionsdele
DK646188A (da) Fremgangsmaade til fremstilling af halogenalkyllactamer
DK61091A (da) Fremgangsmaade til fremstilling af 4-phenylpiperidinderivater
DK390887A (da) Fremgangsmaade til fremstilling af 7alfa-acetylthiosteroider
DK375687D0 (da) Fremgangsmaade til fremstilling af alfa-hydroxycarbonylforbindelser
DK105586A (da) Fremgangsmaade til fremstilling af benzylidenforbindelser
DK504888A (da) Fremgangsmaade til fremstilling af makrolidforbindelser

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment